Altimmune (ALT) Return on Invested Capital (2012 - 2025)

Altimmune (ALT) has 12 years of Return on Invested Capital data on file, last reported at 0.0% in Q4 2025.

• Return on Invested Capital for Q4 2025 came in at 0.0%, changed N/A year-over-year; the trailing twelve-month figure through Dec 2025 was 0.0% (changed N/A YoY), and the FY2025 annual result was 0.0%, changed N/A from the prior year.
• Return on Invested Capital rose to 0.0% in Q4 2025 per ALT's latest filing, from 0.0% in the prior quarter.
• Over five years, Return on Invested Capital peaked at 0.0% in Q1 2021 and troughed at 0.01% in Q1 2025.
• A 3-year average of 0.0% and a median of 0.0% in 2022 frame the typical range for Return on Invested Capital.
• On a YoY basis, Return on Invested Capital climbed as much as 0 bps in 2021 and fell as far as 0 bps in 2021.
• A 3-year view of Return on Invested Capital shows it stood at 0.0% in 2021, then retreated by 19 bps to 0.0% in 2022, then grew by 25 bps to 0.0% in 2025.
• Business Quant data shows ALT's Return on Invested Capital at 0.0% in Q4 2025, 0.0% in Q3 2025, and 0.01% in Q2 2025.